Martel Wealth Advisors’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-2,400
Closed -$217K – 61
2026
Q2
$217K Buy
+2,400
New +$201K 0.03% 58
2026
Q1
– Sell
-2,400
Closed -$205K – 74
2025
Q4
$205K Buy
+2,400
New +$197K 0.03% 70
2025
Q3
– Sell
-2,676
Closed -$209K – 73
2025
Q2
$209K Buy
+2,676
New +$200K 0.04% 68
2024
Q3
– Sell
-2,400
Closed -$222K – 54
2024
Q2
$222K Hold
2,400
– – 0.05% 50
2024
Q1
$229K Buy
+2,400
New +$202K 0.05% 50
2023
Q3
– Sell
-2,400
Closed -$226K – 51
2023
Q2
$226K Buy
+2,400
New +$209K 0.05% 51

Other funds holding EW

Martel Wealth Advisors's EW Position: Q3 2026 in Review

Martel Wealth Advisors sold out of Edwards Lifesciences (EW) in Q3 2026, closing a stake of 2,400 shares — an estimated $217K sold.

Martel Wealth Advisors first reported a position in EW in Q2 2023 and held it in 6 quarters. The position peaked at $229K in Q1 2024. 1,270 funds tracked by Wall St. Rank hold EW as of Q3 2026.

  • Martel Wealth Advisors reported no remaining Edwards Lifesciences position as of Q3 2026 after selling out during the quarter.
  • Martel Wealth Advisors sold 2,400 Edwards Lifesciences shares in Q3 2026, an estimated $217K.
  • Martel Wealth Advisors first reported a position in Edwards Lifesciences in Q2 2023 and held it in 6 quarters.
  • Martel Wealth Advisors's Edwards Lifesciences position peaked at $229K in Q1 2024.
  • 1,270 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2026.

Based on Martel Wealth Advisors's 13F filing for Q3 2026, filed 14 Oct 2026.